Becton Dickinson Seeks Emergency FDA Request To Ramp Up Coronavirus Tests

Diagnostics giant Becton Dickinson said has submitted an emergency request to the U. S. Food and Drug Administration to increase capacity of tests for the has teamed with molecular diagnostics company BioGX and submitted “Emergency Use Authorization” requests to the Food and Drug Administration f…

Read the full post on Forbes - Healthcare